Cryomass Technologies Inc. Logo

Cryomass Technologies Inc.

CRYM

(1.2)
Stock Price

0,02 USD

-745.42% ROA

110% ROE

-0.41x PER

Market Cap.

3.999.845,00 USD

-68.52% DER

0% Yield

-23364.23% NPM

Cryomass Technologies Inc. Stock Analysis

Cryomass Technologies Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Cryomass Technologies Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (-5.3x) suggests it's undervalued, making it an attractive opportunity for investors.

2 DER

The stock has a low debt to equity ratio (-92%), which means it has a small amount of debt compared to the ownership it holds

3 Graham Number

The company's Graham number indicates that it is undervalued compared to its stock price, suggesting a potentially favorable investment opportunity.

4 ROE

Negative ROE (-402.84%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

5 ROA

The stock's ROA (-1213.35%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

6 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

7 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Cryomass Technologies Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Cryomass Technologies Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Buy

Cryomass Technologies Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Cryomass Technologies Inc. Revenue
Year Revenue Growth
2011 973.813
2012 886 -109935.37%
2013 884 -0.23%
2014 844.556 99.9%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 18 100%
2020 781 97.7%
2021 0 0%
2022 0 0%
2023 0 0%
2023 13.552 100%
2024 55.556 75.61%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Cryomass Technologies Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2011 0
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 477.585 100%
2020 0 0%
2021 43.663 100%
2022 20.518 -112.8%
2023 0 0%
2023 13.361 100%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Cryomass Technologies Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2011 0
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 45.969 100%
2017 0 0%
2018 337.770 100%
2019 3.031.211 88.86%
2020 6.557.163 53.77%
2021 7.904.069 17.04%
2022 10.128.891 21.97%
2023 5.372.500 -88.53%
2023 5.610.022 4.23%
2024 4.322.332 -29.79%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Cryomass Technologies Inc. EBITDA
Year EBITDA Growth
2011 -17.678
2012 -17.624 -0.31%
2013 -33.783 47.83%
2014 -2.888 -1069.77%
2015 -28.868 90%
2016 -47.946 39.79%
2017 -47.181 -1.62%
2018 -337.038 86%
2019 -2.871.712 88.26%
2020 -6.534.841 56.06%
2021 -7.948.164 17.78%
2022 -10.149.409 21.69%
2023 -5.372.500 -88.91%
2023 -5.609.830 4.23%
2024 -4.266.760 -31.48%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Cryomass Technologies Inc. Gross Profit
Year Gross Profit Growth
2011 357.270
2012 344 -104060.35%
2013 317 -8.2%
2014 298.925 99.89%
2015 0 0%
2016 0 0%
2017 0 0%
2018 -761 100%
2019 -181 -322.78%
2020 37 586.49%
2021 -43.663 100.08%
2022 -162.401 73.11%
2023 0 0%
2023 -315.671 100%
2024 -65.160 -384.46%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Cryomass Technologies Inc. Net Profit
Year Net Profit Growth
2011 -39.763
2012 -30.898 -28.69%
2013 -65.636 52.93%
2014 -47.237 -38.95%
2015 -93.629 49.55%
2016 -44.145 -112.09%
2017 -56.764 22.23%
2018 -427.457 86.72%
2019 -3.035.255 85.92%
2020 -6.870.678 55.82%
2021 -15.049.602 54.35%
2022 -10.422.691 -44.39%
2023 -5.815.464 -79.22%
2023 -12.955.728 55.11%
2024 -6.478.908 -99.97%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Cryomass Technologies Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2011 0
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Cryomass Technologies Inc. Free Cashflow
Year Free Cashflow Growth
2011 -89.417
2012 -89.908 0.55%
2013 -754 -11824.14%
2014 -22.922 96.71%
2015 -149.659 84.68%
2016 -154 -97081.17%
2017 98 257.14%
2018 -909.071 100.01%
2019 -1.833.139 50.41%
2020 -3.749.621 51.11%
2021 -5.825.512 35.63%
2022 -5.166.702 -12.75%
2023 -899.519 -474.38%
2023 -3.879.216 76.81%
2024 -232.336 -1569.66%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Cryomass Technologies Inc. Operating Cashflow
Year Operating Cashflow Growth
2011 -89.417
2012 -89.908 0.55%
2013 -754 -11824.14%
2014 -22.922 96.71%
2015 -149.659 84.68%
2016 -154 -97081.17%
2017 98 257.14%
2018 -452.453 100.02%
2019 -1.795.318 74.8%
2020 -3.749.621 52.12%
2021 -5.600.512 33.05%
2022 -4.766.864 -17.49%
2023 -874.519 -445.08%
2023 -3.804.980 77.02%
2024 -232.336 -1537.71%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Cryomass Technologies Inc. Capital Expenditure
Year Capital Expenditure Growth
2011 0
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 456.618 100%
2019 37.821 -1107.31%
2020 0 0%
2021 225.000 100%
2022 399.838 43.73%
2023 25.000 -1499.35%
2023 74.236 66.32%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Cryomass Technologies Inc. Equity
Year Equity Growth
2011 201.494
2012 175.262 -14.97%
2013 -231.256 175.79%
2014 -262.259 11.82%
2015 -76.161 -244.35%
2016 -120.306 36.69%
2017 -177.070 32.06%
2018 646.532 127.39%
2019 13.734.420 95.29%
2020 3.605.294 -280.95%
2021 13.524.320 73.34%
2022 4.574.468 -195.65%
2023 -5.849.242 178.21%
2023 -3.417.802 -71.14%
2024 -8.457.310 59.59%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Cryomass Technologies Inc. Assets
Year Assets Growth
2011 631.642
2012 591.039 -6.87%
2013 261.778 -125.78%
2014 196.179 -33.44%
2015 163 -120255.21%
2016 9 -1711.11%
2017 107 91.59%
2018 703.561 99.98%
2019 16.070.008 95.62%
2020 7.798.154 -106.07%
2021 15.583.822 49.96%
2022 7.862.933 -98.19%
2023 972.506 -708.52%
2023 1.072.282 9.31%
2024 1.292.824 17.06%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Cryomass Technologies Inc. Liabilities
Year Liabilities Growth
2011 430.148
2012 415.777 -3.46%
2013 493.034 15.67%
2014 458.438 -7.55%
2015 76.324 -500.65%
2016 120.315 36.56%
2017 177.177 32.09%
2018 57.029 -210.68%
2019 2.335.588 97.56%
2020 4.192.860 44.3%
2021 2.059.502 -103.59%
2022 3.288.465 37.37%
2023 6.821.748 51.79%
2023 4.490.084 -51.93%
2024 9.750.134 53.95%

Cryomass Technologies Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0.04
Price to Earning Ratio
-0.41x
Price To Sales Ratio
122.17x
POCF Ratio
-2.23
PFCF Ratio
-2.35
Price to Book Ratio
-0.44
EV to Sales
283.96
EV Over EBITDA
-1.86
EV to Operating CashFlow
-5.54
EV to FreeCashFlow
-5.46
Earnings Yield
-2.45
FreeCashFlow Yield
-0.43
Market Cap
0,00 Bil.
Enterprise Value
0,01 Bil.
Graham Number
0.19
Graham NetNet
-0.04

Income Statement Metrics

Net Income per Share
-0.04
Income Quality
0.18
ROE
1.41
Return On Assets
-7.81
Return On Capital Employed
0.76
Net Income per EBT
1
EBT Per Ebit
1.91
Ebit per Revenue
-122.33
Effective Tax Rate
-0

Margins

Sales, General, & Administrative to Revenue
153.82
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
2.03
Gross Profit Margin
-1.4
Operating Profit Margin
-122.33
Pretax Profit Margin
-233.06
Net Profit Margin
-233.64

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.01
Free CashFlow per Share
-0.01
Capex to Operating CashFlow
-0.01
Capex to Revenue
0.73
Capex to Depreciation
0.2
Return on Invested Capital
1.95
Return on Tangible Assets
-7.45
Days Sales Outstanding
69
Days Payables Outstanding
10065.93
Days of Inventory on Hand
0
Receivables Turnover
5.29
Payables Turnover
0.04
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
-0,04
Tangible Book Value per Share
-0.04
Shareholders Equity per Share
-0.04
Interest Debt per Share
0.03
Debt to Equity
-0.69
Debt to Assets
4.48
Net Debt to EBITDA
-1.06
Current Ratio
0.08
Tangible Asset Value
-0,01 Bil.
Net Current Asset Value
-0,01 Bil.
Invested Capital
-5237067
Working Capital
-0,01 Bil.
Intangibles to Total Assets
0.05
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
1.45

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Cryomass Technologies Inc. Dividends
Year Dividends Growth

Cryomass Technologies Inc. Profile

About Cryomass Technologies Inc.

Cryomass Technologies Inc. designs, sells, and commercializes cryo-mechanical system for the handling of harvested hemp, cannabis, and other high-value plants. The company was formerly known as Andina Gold Corp. and changed its name to Cryomass Technologies Inc. in August 2021. Cryomass Technologies Inc. was incorporated in 2011 and is headquartered in Denver, Colorado.

CEO
Mr. Christian Noel
Employee
6
Address
1001 Bannock Street
Denver, 80204

Cryomass Technologies Inc. Executives & BODs

Cryomass Technologies Inc. Executives & BODs
# Name Age
1 Mr. Stephen Schroeder
Consultant
70
2 Mr. Christian Noel
Chief Executive Officer & Director
70
3 Ms. Caroline Lenardon
Consultant
70
4 Ms. Janice Matthews
Consultant
70
5 Mr. Philip Blair Mullin B.A., BA, M.B.A., MBA
Chief Financial Officer
70
6 Ms. Patricia I. Kovacevic
General Counsel, Corporate Secretary & Head of External Affairs
70
7 Mr. Ryan Smith
Chief Operating Officer of Good Meds
70

Cryomass Technologies Inc. Competitors